Boston Scientific Overshadowed by Hackers, Headwinds, and Lower Guidance - Boston Scientific (NYSE:BSX)
Boston Scientific slips after a cyber fallout offsets a Q3 consensus beat. Management targets a 2027 cycle trough and 2030 expansion. Boston Scientific Corporation (NYSE:BSX) stock is trading lower after the company issued a weaker-than-expected earnings outlook. The company expects Q4 adjusted earnings of 77-79 cents, below the 84-cent consensus, and a Q4 sales forecast of $5.127 billion-$5.233 billion. CEO Mike Mahoney praised the company's response to a cybersecurity incident, which reduced sales growth by 300 basis points. The firm reported Q3 revenues of $4.138 billion, below management guidance of $ 5.318 billion. Despite this, Boston Scientific plans strategic investments and restructuring to stabilize and grow, aiming to unlock $25 billion in new market opportunities by 2030.
Yayınlanan : 5 saat önce ile Vandana Singh içinde Business Finance Tech
Boston Scientific Corporation (NYSE:BSX) stock is trading lower on Wednesday after the company issued a weaker-than-expected earnings outlook.
CEO Mike Mahoney called it “a challenging year,” but pra... [2293 symbols]
Konular: Markets, Stocks
